Cysteine
In clinical developmentAlso known as (2R)-2-amino-3-mercaptopropanoic acid, (2R)-2-amino-3-sulfanylpropanoic acid, (R)-2-Amino-3-mercaptopropanoic acid, Amino-Cerv+21 more
(2R)-2-amino-3-mercaptopropanoic acid, (2R)-2-amino-3-sulfanylpropanoic acid, (R)-2-Amino-3-mercaptopropanoic acid, Amino-Cerv, Cisteina, Cisteinum, Cys, Elcys, Freamine III 10, Free Cysteine, Hepatamine 8, Hepatasol, L-2-Amino-3-mercaptopropionic acid, L-CYSTEINE, L-Cys, L-Cystein, L-Zystein, Nephramine, Nouress, PremaSol, ProcalAmine 3, Trophamine, Trophamine 10 %, Trophamine 6 %, Cysteinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Protein S-palmitoylation modification: implications in tumor and tumor immune microenvironment.
Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Frontiers in immunology1
- Nature communications1
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics1
- Chen Y1
- Filipovic MR1
- Fu XW1
- Han C1
- Kong LY1
- Li Y1
- Liao ST1
- Wang JS1
- Center for Molecular Metabolism1
- Chongqing University Cancer Hospital1
- Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines1
- School of Molecular Biosciences1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Cysteine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials